Killer-cell immunoglobulin-like receptors (KIRs) Market Report – Research, Industry Analysis Reports and Market Demands

Global Killer-cell immunoglobulin-like receptors (KIRs) Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Killer-cell immunoglobulin-like receptors (KIRs) by Company Revenue
- 3.2.2 Top 3 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
- 3.2.3 Top 6 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
3.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Overall Company Footprint Analysis
- 3.3.1 Killer-cell immunoglobulin-like receptors (KIRs) Market: Region Footprint
- 3.3.2 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
- 3.3.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value and Market Share by Type (2021-2026)
4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2026)
5.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast by Application (2027-2032)

6 North America

6.1 North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
6.2 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2032)
6.3 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
- 6.3.1 North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
- 6.3.2 United States Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 6.3.3 Canada Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
7.2 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
7.3 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
- 7.3.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
- 7.3.2 Germany Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 7.3.3 France Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 7.3.5 Russia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 7.3.6 Italy Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region
- 8.3.1 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2032)
- 8.3.2 China Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 8.3.3 Japan Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 8.3.5 India Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 8.3.7 Australia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)

9 South America

9.1 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
9.2 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
9.3 South America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
- 9.3.1 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
- 10.3.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
- 10.3.4 UAE Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
11.2 Killer-cell immunoglobulin-like receptors (KIRs) Market Restraints
11.3 Killer-cell immunoglobulin-like receptors (KIRs) Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Killer-cell immunoglobulin-like receptors (KIRs) Industry Chain
12.2 Killer-cell immunoglobulin-like receptors (KIRs) Upstream Analysis
12.3 Killer-cell immunoglobulin-like receptors (KIRs) Midstream Analysis
12.4 Killer-cell immunoglobulin-like receptors (KIRs) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Killer-cell immunoglobulin-like receptors (KIRs) market size was valued at US$ 88.49 million in 2025 and is forecast to a readjusted size of US$ 157 million by 2032 with a CAGR of 8.4% during review period.
Killer-cell immunoglobulin-like receptors (KIRs) are a family of transmembrane glycoprotein receptors mainly expressed on natural killer cells and subsets of T cells, and the term also refers to the related commercial products and services built around KIR proteins, KIR genes, ligand recognition, and functional immune analysis. They are not visible stand-alone devices, but molecular receptors located on the cell membrane, typically composed of extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail. Structurally, KIRs can contain two or three extracellular immunoglobulin-like domains, while functionally they include inhibitory and activating receptor types. Commercial products include genotyping kits, sequencing and testing services, flow cytometry antibodies, conjugated antibodies, recombinant proteins, plasmids, cell models, and reference antibodies for drug discovery. Their mechanism is based on recognizing human leukocyte antigen-related ligands and regulating natural killer cell cytotoxicity, immune tolerance, and immune surveillance. Major use scenarios include transplant immunogenetics, natural killer cell research, oncology immunology, immune phenotyping, therapeutic antibody discovery, cell therapy development, and reproductive immunology research.
Market growth opportunities are mainly supported by three demand streams. First, transplant immunogenetics and cell therapy are increasing the need to understand donor-recipient immune background, which supports demand for genotyping, receptor-ligand analysis, and immune risk assessment. Second, the rising importance of natural killer cells in oncology, infectious disease, and autoimmune research is expanding demand for flow cytometry antibodies, recombinant proteins, and functional validation materials. Third, more specific receptor targets are moving part of the market closer to translational development, especially in therapeutic antibody programs, immune monitoring, and potential companion testing workflows.
The main market challenges are clinical evidence, standardization, and commercial scale. These products are used mostly by specialized laboratories, transplant centers, academic institutes, and drug developers, so the customer base is much narrower than that of routine clinical diagnostics. Complex polymorphism, haplotype variation, gene copy number differences, and platform-specific interpretation create technical barriers in quality control and reporting. The value of routine KIR-based decision-making still requires stronger prospective evidence, so near-term market development should be assessed as steady professional adoption rather than mass-market expansion.
Downstream demand is expected to shift from single-product purchasing toward integrated solutions. Transplant-related users will increasingly combine genotyping, ligand matching, and long-term outcome data. Oncology immunology users will focus more on receptor expression, immune-cell functional status, and treatment response monitoring. Drug developers will require higher target specificity, antibody affinity validation, cytotoxicity mechanism studies, and clinical sample-based evidence. Faster-growing product categories are likely to include high-throughput typing, conjugated antibody panels, recombinant proteins, reference antibodies, and testing services designed for clinical research.
This report is a detailed and comprehensive analysis for global Killer-cell immunoglobulin-like receptors (KIRs) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Killer-cell immunoglobulin-like receptors (KIRs)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Killer-cell immunoglobulin-like receptors (KIRs) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Becton Dickinson, Beckman Coulter Life Sciences, Bio-Rad, Revvity, Bio-Techne, Miltenyi Biotec, Merck, Abcam, Werfen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Killer-cell immunoglobulin-like receptors (KIRs) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
KIR Genotyping Products and Services
KIR/CD158 Antibodies and Flow Cytometry Reagents
Recombinant KIR Proteins and Related Research Reagents
Market segment by Target Structure
2D KIR Products
3D KIR Products
Pan-KIR or Mixed KIR Panel Products
Market segment by Function
Inhibitory KIR-related Products
Activating KIR-related Products
Mixed KIR Panel Products
Market segment by Application
Medical Science
Experiment
Other
Market segment by players, this report covers
Thermo Fisher Scientific
Becton Dickinson
Beckman Coulter Life Sciences
Bio-Rad
Revvity
Bio-Techne
Miltenyi Biotec
Merck
Abcam
Werfen
CareDx
GenDx
HistoGenetics
DKMS Life Science Lab
Scisco Genetics
Labcorp
GeneTex
Proteintech
Cell Signaling Technology
OriGene
MyBioSource
Aviva Systems Biology
NSJ Bioreagents
Boster Bio
KACTUS
ProteoGenix
Biorbyt
Abbexa
St John’s Laboratory
Innate Pharma
ACROBiosystems
Sino Biological
GenScript
CUSABIO
Solarbio
WeHelp
CapitalBio
Genomeditech
Abnova
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Killer-cell immunoglobulin-like receptors (KIRs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Killer-cell immunoglobulin-like receptors (KIRs), with revenue, gross margin, and global market share of Killer-cell immunoglobulin-like receptors (KIRs) from 2021 to 2026.
Chapter 3, the Killer-cell immunoglobulin-like receptors (KIRs) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Killer-cell immunoglobulin-like receptors (KIRs) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Killer-cell immunoglobulin-like receptors (KIRs).
Chapter 13, to describe Killer-cell immunoglobulin-like receptors (KIRs) research findings and conclusion.

Buy now